欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/1678/001
药品名称Sildenafil Farmalider
活性成分
    • sildenafil citrate 35.1 mg/ml
剂型Oral suspension
上市许可持有人Farmalider, S.A.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Austria (AT)
    • Belgium (BE)
    • Bulgaria (BG)
    • Croatia (HR)
    • Czechia (CZ)
      Azurvig 25 mg/ml perorální suspenze
    • France (FR)
    • Germany (DE)
      Azurvig 25 mg/ml Suspension zum Einnehmen
    • Greece (GR)
      SILDENAFIL/FARMALIDER
    • Hungary (HU)
    • Italy (IT)
    • Romania (RO)
    • Slovakia (SK)
    • Spain (ES)
    • United Kingdom (GB)
    • Poland (PL)
      Sildenafil Farmalider
许可日期2017/10/04
最近更新日期2017/12/11
药物ATC编码
    • G04BE03 sildenafil
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase